- Home
- UNCY vs PGP Comparison
UNCY vs PGP Comparison
Compare UNCY & PGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- PGP
- Stock Information
- Founded
- UNCY 2016
- PGP 2003
- Country
- UNCY United States
- PGP United States
- Employees
- UNCY N/A
- PGP N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- PGP Finance Companies
- Sector
- UNCY Health Care
- PGP Finance
- Exchange
- UNCY Nasdaq
- PGP Nasdaq
- Market Cap
- UNCY 91.0M
- PGP 96.2M
- IPO Year
- UNCY 2021
- PGP N/A
- Fundamental
- Price
- UNCY $4.87
- PGP $8.34
- Analyst Decision
- UNCY Strong Buy
- PGP
- Analyst Count
- UNCY 4
- PGP 0
- Target Price
- UNCY $63.75
- PGP N/A
- AVG Volume (30 Days)
- UNCY 934.5K
- PGP 39.8K
- Earning Date
- UNCY 08-13-2025
- PGP 01-01-0001
- Dividend Yield
- UNCY N/A
- PGP 10.84%
- EPS Growth
- UNCY N/A
- PGP N/A
- EPS
- UNCY N/A
- PGP N/A
- Revenue
- UNCY N/A
- PGP N/A
- Revenue This Year
- UNCY N/A
- PGP N/A
- Revenue Next Year
- UNCY $1,458.53
- PGP N/A
- P/E Ratio
- UNCY N/A
- PGP N/A
- Revenue Growth
- UNCY N/A
- PGP N/A
- 52 Week Low
- UNCY $2.02
- PGP $5.83
- 52 Week High
- UNCY $11.00
- PGP $7.81
- Technical
- Relative Strength Index (RSI)
- UNCY 45.55
- PGP 60.31
- Support Level
- UNCY $4.38
- PGP $8.18
- Resistance Level
- UNCY $4.96
- PGP $8.35
- Average True Range (ATR)
- UNCY 0.31
- PGP 0.07
- MACD
- UNCY 0.05
- PGP -0.01
- Stochastic Oscillator
- UNCY 41.88
- PGP 66.67
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About PGP Pimco Global StocksPlus & Income Fund of Beneficial Interest
PIMCO Global Stocksplus & Income Fund is a closed-end management investment company. The objective of the fund is to seek a total return comprised of current income, current gains, and long-term capital appreciation. The fund invests a majority of the fund's net assets in a combination of securities and instruments that provide exposure to stocks and or produce income.